TXG logo

10x Genomics (TXG) Cash from operations

annual CFO:

$6.66M+$21.86M(+143.85%)
December 31, 2024

Summary

  • As of today (May 24, 2025), TXG annual cash flow from operations is $6.66 million, with the most recent change of +$21.86 million (+143.85%) on December 31, 2024.
  • During the last 3 years, TXG annual CFO has risen by +$28.04 million (+131.18%).
  • TXG annual CFO is now -80.75% below its all-time high of $34.63 million, reached on December 31, 2019.

Performance

TXG Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

quarterly CFO:

$34.35M+$41.10M(+609.05%)
March 31, 2025

Summary

  • As of today (May 24, 2025), TXG quarterly cash flow from operations is $34.35 million, with the most recent change of +$41.10 million (+609.05%) on March 31, 2025.
  • Over the past year, TXG quarterly CFO has increased by +$50.08 million (+318.45%).
  • TXG quarterly CFO is now at all-time high.

Performance

TXG quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM CFO:

$56.74M+$50.08M(+751.44%)
March 31, 2025

Summary

  • As of today (May 24, 2025), TXG TTM cash flow from operations is $56.74 million, with the most recent change of +$50.08 million (+751.44%) on March 31, 2025.
  • Over the past year, TXG TTM CFO has increased by +$83.54 million (+311.74%).
  • TXG TTM CFO is now at all-time high.

Performance

TXG TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TXG Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+143.8%+318.4%+311.7%
3 y3 years+131.2%+265.1%+248.9%
5 y5 years-80.8%+1433.5%+149.6%

TXG Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+119.8%at high+235.8%at high+197.5%
5 y5-year-80.8%+103.1%at high+126.4%at high+125.9%
alltimeall time-80.8%+103.1%at high+126.4%at high+125.9%

TXG Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$34.35M(-609.1%)
$56.74M(+751.4%)
Dec 2024
$6.66M(-143.9%)
-$6.75M(-131.2%)
$6.66M(-83.0%)
Sep 2024
-
$21.64M(+188.7%)
$39.17M(-603.8%)
Jun 2024
-
$7.50M(-147.7%)
-$7.78M(-71.0%)
Mar 2024
-
-$15.72M(-161.0%)
-$26.80M(+76.3%)
Dec 2023
-$15.20M(-54.8%)
$25.76M(-201.8%)
-$15.20M(-44.2%)
Sep 2023
-
-$25.30M(+119.5%)
-$27.23M(+137.0%)
Jun 2023
-
-$11.53M(+179.4%)
-$11.49M(-32.1%)
Mar 2023
-
-$4.13M(-130.1%)
-$16.93M(-49.6%)
Dec 2022
-$33.61M(+57.2%)
$13.72M(-243.5%)
-$33.61M(-19.1%)
Sep 2022
-
-$9.56M(-43.6%)
-$41.52M(-28.6%)
Jun 2022
-
-$16.96M(-18.5%)
-$58.18M(+52.7%)
Mar 2022
-
-$20.80M(-458.3%)
-$38.09M(+78.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$21.37M(-90.2%)
$5.80M(-122.1%)
-$21.37M(-86.4%)
Sep 2021
-
-$26.22M(-940.3%)
-$157.35M(-15.7%)
Jun 2021
-
$3.12M(-176.4%)
-$186.77M(-14.9%)
Mar 2021
-
-$4.08M(-96.9%)
-$219.40M(+0.7%)
Dec 2020
-$217.90M(-729.3%)
-$130.18M(+134.0%)
-$217.90M(+168.9%)
Sep 2020
-
-$55.63M(+88.5%)
-$81.02M(+645.5%)
Jun 2020
-
-$29.52M(+1045.9%)
-$10.87M(-147.8%)
Mar 2020
-
-$2.58M(-138.4%)
$22.73M(-34.3%)
Dec 2019
$34.63M(-145.3%)
$6.70M(-53.9%)
$34.63M(+24.0%)
Sep 2019
-
$14.53M(+255.8%)
$27.93M(+108.4%)
Jun 2019
-
$4.08M(-56.2%)
$13.40M(+43.8%)
Mar 2019
-
$9.32M
$9.32M
Dec 2018
-$76.41M(+614.2%)
-
-
Dec 2017
-$10.70M
-
-

FAQ

  • What is 10x Genomics annual cash flow from operations?
  • What is the all time high annual CFO for 10x Genomics?
  • What is 10x Genomics annual CFO year-on-year change?
  • What is 10x Genomics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for 10x Genomics?
  • What is 10x Genomics quarterly CFO year-on-year change?
  • What is 10x Genomics TTM cash flow from operations?
  • What is the all time high TTM CFO for 10x Genomics?
  • What is 10x Genomics TTM CFO year-on-year change?

What is 10x Genomics annual cash flow from operations?

The current annual CFO of TXG is $6.66M

What is the all time high annual CFO for 10x Genomics?

10x Genomics all-time high annual cash flow from operations is $34.63M

What is 10x Genomics annual CFO year-on-year change?

Over the past year, TXG annual cash flow from operations has changed by +$21.86M (+143.85%)

What is 10x Genomics quarterly cash flow from operations?

The current quarterly CFO of TXG is $34.35M

What is the all time high quarterly CFO for 10x Genomics?

10x Genomics all-time high quarterly cash flow from operations is $34.35M

What is 10x Genomics quarterly CFO year-on-year change?

Over the past year, TXG quarterly cash flow from operations has changed by +$50.08M (+318.45%)

What is 10x Genomics TTM cash flow from operations?

The current TTM CFO of TXG is $56.74M

What is the all time high TTM CFO for 10x Genomics?

10x Genomics all-time high TTM cash flow from operations is $56.74M

What is 10x Genomics TTM CFO year-on-year change?

Over the past year, TXG TTM cash flow from operations has changed by +$83.54M (+311.74%)
On this page